Blue toe syndrome is when one or more toes suddenly turn blue or purple and painful, usually because tiny particles, most often cholesterol crystals from a hardened artery upstream, have blocked the smallest arteries of the toes, often while the foot pulses can still be felt. It needs medical care the same day, even if the color fades, because it is a warning about the arteries or heart upstream, which can send more debris to the toes, kidneys, gut, eyes or brain. It mostly affects older adults with hardened arteries, often in the weeks after a heart catheterization or another artery procedure, and occasionally after starting a blood thinner. This guide covers the signs, causes, tests, treatment and outlook.
When a blue or purple toe needs urgent care
- A whole foot or leg that suddenly turns cold, pale or blue, numb, weak or very painful, or a whole leg that suddenly swells and turns blue: call 911. A main artery, or the leg veins, may be blocked.
- Blue toes with signs of a stroke or sudden loss of vision in one eye, even if they pass within minutes, or with new confusion or severe belly pain: call 911. The same debris can block arteries in the brain, eyes and gut.
- Toes that turn black, gray or dark purple, or look dead, or redness, pus or a bad smell spreading from a toe: go to an emergency department now, and have someone else drive you; the UK’s NHS advises emergency care for suspected gangrene. Call 911 if you also have shivering, confusion, very fast breathing, or blotchy skin or a rash that does not fade when pressed, which can mean sepsis.
- Any new, painful blue or purple toe without an injury, especially within weeks of a heart catheterization, angiogram, stent, vascular surgery, or starting a blood thinner or clot-busting drug: get same-day care, even if your foot pulses feel normal and the color fades, because more debris can follow in the coming weeks. Keep taking your medicines unless a clinician tells you otherwise.
- A blue toe with possible kidney symptoms, such as peeing much less than usual, new leg swelling, nausea or breathlessness when lying down: mention them at your same-day visit. Kidney injury from cholesterol emboli is often silent, so ask for a creatinine blood test anyway.
- Any color change in your feet if you have diabetes or numb feet: call your doctor or podiatrist the same day, because nerve damage can hide the warning pain.
On brown or black skin, color changes in a toe can be harder to see. Compare it with the toes beside it and with the other foot, and go by pain, coldness and how fast it is changing.
What is blue toe syndrome?
A 2009 dermatology review defines it as “blue or violaceous discoloration of one or more toes in the absence of obvious trauma, serious cold-induced injury, or disorders producing generalized cyanosis”, meaning conditions such as low blood oxygen that turn the whole body blue. It is also called purple toe syndrome. It is a sign, not one disease: in the classic form, debris from a larger artery travels down a leg whose main arteries are still open and lodges in the tiny arteries of the toes. A 1976 report of 31 patients compared it to a mini-stroke: “It is closely analogous to the transient ischemic attacks of the brain, and carries the same potential for serious tissue loss because of repeated embolic showers.”
What it looks like
- Color: one or more toes, or patches on the sole, turn blue, purple or violet, while the rest of the foot often looks normal and feels warmer. A lacy purple pattern (livedo reticularis) often appears on the feet and legs. Early on, the color may fade with pressure or when the leg is raised.
- Pain: DermNet, a dermatology reference, says, “Pain in the affected blue toe or toes is usually of acute onset and occurs at rest.”
- Pulses: the blocked arteries are too small to feel, so the foot pulses are often normal. Many people also have narrowed leg arteries, though, so weak pulses do not rule it out.
- Later: severe blockage can cause ulcers or black, dead skin (gangrene). Among published cases of cholesterol emboli with skin signs, livedo appeared in 49%, gangrene in 35% and ulcers in 17%.
When it appears
Blue toes can appear within hours or days of an artery procedure, but often later: one review describes skin signs appearing more than a month after the trigger, and the Merck Manual shows painful blue toes 6 weeks after coronary stenting. Kidney damage from the same showers usually builds over 3 to 8 weeks. So a procedure in the past two months, or a blood thinner started in the past few months, still counts.
What causes blue toe syndrome?
A toe loses its blood supply in one of three ways: its small arteries are blocked or narrowed, most often by debris from upstream but sometimes by inflammation, spasm or calcium deposits; blood cannot drain through the veins; or the blood itself clots or thickens. Upstream debris is the commonest. In the only breakdown we found that also counts causes outside the arteries, a Polish vascular series of 165 people with blue toes or fingers, scans found a possible artery source in 146.
Cholesterol crystal emboli, the cause named most often
DermNet sums it up: “Cholesterol emboli are cholesterol fragments or fibrin–platelet material released into the bloodstream from ulcerated arteriosclerotic plaques in the large arteries (eg, the aorta, and the iliac and femoral arteries) and are the most common cause of blue toe syndrome.” The crystals plug the smallest arteries and inflame them. A 2019 review estimates that about 70% of cases follow a procedure on the heart or arteries, most often angiography. In a prospective study in Japan of 1,786 people having a left-heart catheterization, 25 (1.4%) developed cholesterol emboli, about half of them with skin signs such as blue toes; a definite diagnosis was made in 0.8% of the 1,786. Rates of noticeable cholesterol emboli reported across studies range from 0.09% to 2.9%, while one older autopsy study found crystals in 25% to 30% of people who died within six months of angiography, against about 4% of similar people who had not had it, so many showers probably cause no symptoms. Others happen spontaneously: in 23.5% of 354 people with kidney involvement, and 62% of a US surgical series of 62 people treated for skin signs.
Blood thinners and clot-busting drugs
The US label for warfarin warns: “Anticoagulation therapy with JANTOVEN may enhance the release of atheromatous plaque emboli.” (Jantoven is a brand of warfarin.) The label for the clot-busting drug alteplase lists purple toes among the signs of cholesterol embolism, which it says has been reported rarely, though its true frequency is unknown. Yet most people affected had also had a procedure, and among 519 people with severe aortic plaque, cholesterol emboli developed in 1% of those taking warfarin and 1% of those not. A 2010 review in the journal Circulation concluded that “one cannot definitively either prove or disprove the causal relationship between cholesterol embolization syndrome and anticoagulation and/or thrombolytic therapy.”
Plaque and clots from narrowed arteries and aneurysms
A narrowed or bulging artery anywhere from the aorta to the knee can also shed plaque, or small clots that formed on its surface, and one person can have both. In the Polish series, the sources were short, tight narrowings or unstable plaque in 73 people, true aneurysms (bulges in the artery wall, mostly in the abdominal aorta or thigh artery) in 42, false aneurysms in 17, 8 of them after catheter procedures through the groin, and problems with earlier bypass grafts in 11. Blue toes on both feet point to the aorta; on one foot, usually to an artery in that leg.
Clots from the heart
Clots from the heart, for example in atrial fibrillation, and material from an infected heart valve (endocarditis) or a heart tumor (myxoma) can also reach the toes, though a larger heart clot tends to block a main leg artery instead. We found no reliable figures for how often the heart is the source. Fever with a new heart murmur suggests endocarditis.
Causes that are not emboli
Of the 19 people in the Polish series with no artery source, 11 had a tendency to clot (thrombophilia), 2 had very high platelet counts and 3 had widespread clotting after aortic surgery; only 3 had no cause found. These are small numbers, so treat them as rough. Other causes include:
- Clotting and blood disorders such as antiphospholipid syndrome, an autoimmune clotting disorder, and polycythemia vera, which thickens the blood.
- Buerger’s disease, an inflammatory blockage of small arteries that mostly affects men aged 20 to 45 who smoke heavily or chew tobacco; stopping all tobacco is the key treatment.
- Calciphylaxis, calcium deposits that block small skin vessels, mainly in people on dialysis.
- Others: vasculitis, cold-sensitive blood proteins (cryoglobulins), severe infection, cocaine, and a massive clot in the leg veins (phlegmasia cerulea dolens) that leaves the whole leg swollen, blue and very painful.
Who gets blue toe syndrome?
Mostly older people with widespread hardening of the arteries: in the study of 354 people with kidney involvement, 83% were men, 60% were over 70 and 90% had heart or blood vessel disease. The risk is higher if you smoke, have high blood pressure, high cholesterol or diabetes, have an aortic aneurysm or other artery disease, have atrial fibrillation, or have recently had an artery procedure or started a blood thinner. In the Japanese catheterization study, a raised C-reactive protein, a blood marker of inflammation, before the procedure was the only independent predictor, and going in through the groin was no riskier than through the arm. Diabetes matters twice: it hardens arteries, and nerve damage can dull the warning pain. Risk factors for artery disease →
Blue toe syndrome vs Raynaud’s and other look-alikes
These are the conditions most often confused with blue toe syndrome.
| Condition | What it looks like | What sets it apart | How urgent |
|---|---|---|---|
| Blue toe syndrome | One or a few toes suddenly blue or purple and painful | Pain at rest; lasts days; often after a procedure; foot pulses may be normal | Same day; emergency department now if a toe turns black, gray or dark purple, or looks dead |
| Raynaud’s phenomenon | Toes or fingers turn white, sometimes blue, then red as they rewarm | Set off by cold or stress; passes in minutes to hours | Routine; prompt appointment if only one side is affected; same day for a sore, a new dark patch, or a toe that stays dusky blue or purple after warming; emergency department now for a toe that is black, gray or dark purple or looks dead |
| Chilblains | Itchy or burning red to purple swellings | Hours after damp cold; clear in 2–3 weeks | Self-care for itchy red or purple patches that are fading; same day if a toe stays dusky blue or purple, for pus or spreading redness, or for a sore with diabetes, numb feet or poor circulation; emergency department now for a toe that is black, gray or dark purple or looks dead, redness spreading fast, or a fever or chills |
| Acrocyanosis | Even, painless blue color of both hands and feet | Long-standing and symmetrical; no sores; normal pulses | Routine; same day if new, one-sided or painful |
| Frostbite | Hard, frozen skin that is white, blue or blotchy | After exposure to 32°F (0°C) or below | Emergency |
| Bruise or blood under a toenail | Maroon to black under the nail, or a bruised toe | After a knock, tight shoes or long runs; throbbing pain | Prompt care if large or very painful |
| Peripheral artery disease with gangrene | Dry, black toe or ulcer; foot pale when raised | Months of calf pain on walking or pain at night first; foot pulses absent | Same day; emergency department now if a toe is black, gray or dark purple or looks dead, or is infected |
| Livedo reticularis | Lacy, net-like purple pattern on the legs | Often harmless in the cold; persistent livedo with painful toes suggests emboli | Routine; same day with painful toes |
- Raynaud’s attacks pass. In the NHS’s words, “The symptoms of Raynaud’s may last from a few minutes to a few hours.” A toe that stays blue and painful needs a same-day check. Raynaud’s: symptoms and treatment →
- Acrocyanosis is usually harmless, but DermNet warns: “Secondary acrocyanosis is often asymmetrical and is associated with pain and tissue damage (blue toe syndrome).” Acrocyanosis →
- Chilblains itch or burn and follow cold, damp weather. Chilblains →
- Livedo reticularis is normal in the cold for many babies and adults, but livedo that stays, especially with painful toes, needs a check. Livedo reticularis →
- Artery disease usually builds gradually, often with calf pain on walking before a toe darkens. Peripheral artery disease symptoms →
- A dark spot under a nail with no injury needs checking, because it can look like melanoma. Other foot color changes →
What to do if a toe suddenly turns blue or purple
- Get seen today. Call the team who did any recent procedure or your own doctor; if you cannot be seen today, go to an emergency department. The box above says when to call 911.
- Mention the past few months. Tell them about any catheterization, angiogram, stent, surgery or new blood thinner, even if it went smoothly. The warfarin medication guide says: “Call your healthcare provider right away if you have pain in your toes and they look purple in color or dark in color.”
- Keep taking your medicines. Do not stop a blood thinner or aspirin on your own; it may be protecting you from a stroke.
- Ask about your kidneys. Ask for a creatinine test and a blood count with eosinophils. The NHS notes: “Many people do not get symptoms of acute kidney injury (AKI), especially if it’s mild.” A normal first result does not settle it, because kidney damage from cholesterol emboli can keep building for 3 to 8 weeks, so ask when your creatinine should be rechecked.
- Protect the toe. Keep it clean and dry in roomy shoes, with no heating pads, hot water bottles or soaking, and no compression socks until your arteries have been checked.
- Bring a list of your medicines, procedures and when the toe changed, plus daily photos. Preparing for your appointment →
How blue toe syndrome is diagnosed
Recognizing the toe is the easy part; finding the source decides the treatment. A 2010 Lancet review describes the classic picture of cholesterol emboli as a triggering event, kidney failure developing over days to weeks, and skin changes, with high eosinophils adding weight.
- Blood and urine tests. The Circulation review notes, “Hypereosinophilia has been reported in up to 80% of the patients with cholesterol embolization syndrome,” but high eosinophils (a type of white blood cell) often last only a few days, and other series report them in 14% to 71%, so a normal count does not rule emboli out. A creatinine test checks the kidneys: injury from contrast dye usually appears within 2 to 3 days and improves within a week, while injury from emboli builds over weeks. Other tests depend on the suspected cause, such as clotting tests, antiphospholipid antibodies, cryoglobulins, and blood cultures if endocarditis is possible.
- Ankle and toe pressures. In a 1986 toe-pressure study of 67 limbs with blue toes, the ankle-brachial index was abnormal in 47%, but the ratio of toe to ankle pressure in 85%. Ankle and toe pressure tests →
- Duplex ultrasound. The Polish team concluded that “Duplex Doppler ultrasound of the arteries in the affected limb with a full length view should be the first-line examination in diagnosing patients with BTS”, meaning blue toe syndrome. Vascular ultrasound →
- CT angiography and echocardiography. CT, or MRI, shows plaque and aneurysms in the aorta. An echocardiogram looks for heart clots, infected valves or tumors, and a transesophageal echo, passed down the esophagus (food pipe), measures plaque in the chest aorta. Catheter angiography is usually kept for when a repair is planned, because it can release more debris. CT, MRI and angiography →
- Eye exam. Looking at the back of the eye can show cholesterol crystals stuck in its arteries (Hollenhorst plaques), seen in about 10% to 25% of people with cholesterol emboli. Like a biopsy, finding them can confirm the diagnosis, though they can linger from an older shower.
- Biopsy. A small tissue sample, usually from affected skin or muscle, is the surest test: the crystals leave needle-shaped clefts in small arteries, and in a review of published cases already proved under the microscope, a skin biopsy showed them 92% of the time. But DermNet cautions: “Biopsies in patients with a poor peripheral vascular supply should be performed with caution as poor healing is likely at the sampling site.” Many diagnoses are made without a biopsy.
Blue toe syndrome treatment
Treatment aims to stop more debris arriving and to save the damaged tissue. It rests on case series, observational studies and expert opinion rather than large trials.
Finding and fixing the source
The 1976 report urged that “The prompt delineation and eradication of the embolic source is of prime importance”. A single culprit, such as an aneurysm or a short, tight narrowing, can be bypassed, cleaned out (endarterectomy) or lined with a stent. In the US series of 62 people, mostly treated with bypass or endarterectomy, no further emboli reached the treated legs over an average of 20 months and 98% of limbs were saved; 5% died within 30 days. In another small series, 1 of 30 people selected for surgery on their source had another embolus, against 4 of 11 who did not have surgery, but the 1986 toe-pressure study found outcomes no better after surgery than with medicines or no treatment. Stents have been reported in small numbers of patients. But many people have plaque along the whole aorta, and handling it can start a new shower; a 2019 review advises that for cholesterol emboli, “surgery should be considered only as rescue therapy in life-threatening situations”. If you have had cholesterol emboli, tell any doctor planning an angiogram, catheter procedure or artery surgery, so the benefit can be weighed against the risk of another shower. Artery procedures explained →
Statins and antiplatelet medicines
Statins are the best-supported medicine. In the study of 354 people with kidney involvement, “The risk of dialysis and death was 50% lower among those receiving statins,” and among 519 people with severe aortic plaque, statin users had fewer strokes and emboli. Neither study was randomized, and the Circulation review notes: “Unfortunately, there has been no randomized trial of statin therapy in patients with severe aortic plaque.” Even so, the Lancet review advises: “Statins, which stabilise atherosclerotic plaques, should be offered to all patients.” For aspirin and similar drugs, “There is no direct evidence that antiplatelet agents prevent the recurrence of cholesterol embolization syndrome,” the Circulation review says, but they help prevent heart attacks and strokes, so they are usually recommended anyway.
Blood thinners: why the advice conflicts
The right answer depends on what the debris is made of, and the sources disagree.
- Cholesterol emboli: usually not started. The Merck Manual states: “There is no demonstrated benefit of anticoagulation and, according to most experts, its use may actually enhance atheroembolism.” The Circulation authors wrote: “In our own practice, we do not recommend the use of anticoagulation therapy in patients with cholesterol embolization syndrome unless there is a separate indication such as atrial fibrillation or mechanical prosthetic valve.” In one kidney intensive care unit that stopped all blood thinners, needing dialysis was linked to earlier blood-thinner use.
- Stopping one has risks too. It may be preventing a stroke. In the study of 519 people with severe aortic plaque, cholesterol emboli were no more common with warfarin than without it, though only 5 people had them, and a 2020 French-language review concluded that stopping these drugs “should be considered in terms of the benefit-risk balance, but often in favour of maintaining it.”
- Clots: a blood thinner is the treatment. For emboli from the heart in atrial fibrillation, a clot that keeps shedding emboli, or antiphospholipid syndrome, anticoagulation is standard.
The warfarin label tells prescribers to stop it if purple toes appear and to consider another drug if anticoagulation is still needed. That is your doctors’ decision; never stop or start a blood thinner on your own.
Steroids and other medicines
Because the crystals inflame the vessels they block, steroids have been tried, mostly for kidney damage. A 2024 review found that “There is encouraging but thin evidence supporting their efficacy, derived from a few case reports, obviously highlighting the need for confirmation in large, randomized trials,” and the Merck Manual counts steroids among treatments that do not help once emboli reach the kidneys. Iloprost, pentoxifylline and other drugs have had limited success in reports.
Wound, pain and kidney care
DermNet lists the basics: “Supportive and symptomatic treatments of blue toe syndrome include rest, warm conditions, appropriate dressings, and hydration”. Warm conditions means a warm room and socks, not direct heat on the toe. Pain can be severe and deserves proper treatment. Wounds heal slowly: of 58 people with leg or foot wounds from cholesterol emboli, 55.1% had healed at one year, and healing was worse than for similar wounds from ordinary artery blockage. Kidney involvement needs blood pressure and fluid control, and sometimes dialysis. A foot wound that will not heal →
Is blue toe syndrome dangerous? The outlook
It can be; the risk depends on what lies behind the toe. Figures vary because studies looked at very different groups.
- Survival: after heart catheterization, 16.0% of people who developed cholesterol emboli died in hospital, against 0.5% of those who did not, and all who died had worsening kidney failure. A kidney intensive care unit also reported 16% in-hospital deaths, with 87% of its patients alive at one year.
- Kidneys: of the 354 people with kidney involvement, 116 needed dialysis and 102 died over about 2 years; the Merck Manual puts the share needing dialysis at one third to one half.
- Amputation: 22% of the 64 legs followed in the 1986 toe-pressure study (7 toe, 3 forefoot and 4 leg amputations); in the US surgical series, 31% of people needed a minor amputation and 2 a major leg amputation; at least 8 of 165 in the Polish series.
Older reviews quote death rates of 72% or more, but many of those cases were found only at autopsy; a 2019 review notes that mortality was “as high as 80% when cases that had been diagnosed postmortem were included.” Such figures overstate the risk for someone diagnosed and treated today.
Mild blue toe syndrome: does it go away on its own?
Mild cases can settle: DermNet notes that “Mild forms of blue toe syndrome have a good prognosis and subside without sequelae”, meaning without lasting damage. In the 1986 toe-pressure study, though, only 44% of legs followed for about 2 years had a trouble-free course. And a fading toe does not mean the source has gone. The US surgical team warned: “Seemingly minor blue-toe lesions resulting from atheroemboli are associated with unstable atherosclerotic plaques, which are at risk for causing recurrent emboli, tissue loss, and potentially death.” Repeat emboli occurred in 15% of 41 people over about 2 years in one small series, and in 4 of the 11 whose source was not repaired. Whether a case is mild is decided after the source has been looked for.
Looking after the toe: what a podiatrist does
- Take pressure off with roomy, soft shoes or a postoperative shoe, and avoid tight socks and narrow shoes. No compression socks or stockings until your arteries have been checked.
- Keep heat off. The National Institute of Diabetes and Digestive and Kidney Diseases advises: “Do not put a hot water bottle or heating pad on your feet.” We apply the same rule to any toe with poor feeling or blood supply, including heated socks and foot warmers. Heated socks: who should skip them →
- Wash gently. The CDC advises: “Wash your feet every day in warm (not hot) water. Don’t soak your feet.”
- Cover any break with a clean, non-stick dressing. Do not cut, pick or pop anything; let your clinician decide whether dead tissue should be removed.
- Watch for infection. Spreading redness, pus, a bad smell or a toe that turns black, gray or dark purple, or looks dead needs an emergency department now, as in the box above; call 911 if you also have a fever with shivering, confusion or very fast breathing. Swelling alone needs a same-day check.
- Stop smoking. Building a quit plan →
A podiatrist can check pulses and toe pressures, rule out look-alikes, dress and offload the toe, trim nails safely, and recognize when a toe needs a vascular surgeon that day. Planned toe or nail surgery is best postponed until the circulation has been assessed, because cuts heal poorly where blood flow is poor. Daily foot and leg skin checks →
Near Howell or Bloomfield Township, Michigan?
The author of this site practices podiatry at Balance Foot & Ankle, which he owns, so this is a disclosed option rather than an independent referral. A toe that has suddenly turned blue or purple needs same-day care first, from your doctor, the team that did a recent procedure, or an emergency department. After that, or for toe color changes that come and go, an evaluation can check the circulation and skin of your feet, dress and protect a damaged toe, adjust footwear to take pressure off it, and coordinate with your vascular, heart and kidney doctors. Michigan evaluation →
Common questions
What is blue toe syndrome?
It is the sudden appearance of one or more painful blue or purple toes without an injury, frostbite or a condition that turns the whole body blue. It usually means tiny particles, most often cholesterol crystals from hardened arteries, have blocked the toes’ smallest arteries, often while the foot pulses can still be felt. It is a warning about the arteries or heart upstream and needs same-day care.
What causes blue toe syndrome?
Most often cholesterol crystal emboli: debris from fatty plaque in the aorta or leg arteries, often loosened by a heart catheterization, angiogram or artery surgery. Other causes include plaque or clots from an aneurysm or narrowed artery, clots from the heart, clotting disorders such as antiphospholipid syndrome, blood disorders such as polycythemia vera, Buerger’s disease in smokers, vasculitis and calciphylaxis.
Is blue toe syndrome an emergency?
It needs same-day care, even if the color fades, because more debris can follow within weeks and the kidneys can be damaged without symptoms. Call 911 if a whole foot or leg turns cold, pale, numb, weak or very painful, if a whole leg suddenly swells and turns blue, or if blue toes come with signs of a stroke, sudden loss of vision in one eye (even if it comes back), new confusion or severe belly pain. Go to an emergency department now if a toe turns black, gray or dark purple, or looks dead, or if redness, pus or a bad smell spreads from it, and call 911 if you also feel very unwell.
Can blue toe syndrome go away on its own?
Mild cases can settle without lasting damage, and the color may fade. But fading does not mean the source has gone: the plaque or clot can send more debris to the toes, kidneys or brain, and seemingly minor blue toes have been linked to unstable plaque. Get it checked the same day even if it is improving.
How is blue toe syndrome treated?
By dealing with the source and protecting the toe: usually a statin and often aspirin, risk-factor control, and sometimes surgery or a stent for a single culprit artery. A blood thinner is the treatment when the source is a clot, but is usually not started for cholesterol emboli without another reason. Wound care, pain relief and kidney checks complete it.
Can you get blue toe syndrome after a heart catheterization?
Yes. In a study of 1,786 people having a left-heart catheterization, 1.4% developed cholesterol emboli, about half of them with skin signs such as blue toes. Signs can appear days to weeks later. If a toe turns blue and painful after a catheterization or stent, call the team that did it or get same-day care, and ask for a kidney blood test.
What is the difference between blue toe syndrome and Raynaud’s?
Raynaud’s causes attacks, set off by cold or stress, in which the toes or fingers turn white, sometimes blue, then red, and return to normal within minutes to hours. Blue toe syndrome comes on suddenly, often in one or a few toes, hurts even at rest and lasts for days. A toe that stays blue and painful needs same-day care.
Can blood thinners cause blue toes?
Possibly, though rarely. The US labels for warfarin and the clot-busting drug alteplase warn about cholesterol emboli and purple toes, but studies have not proved that the drugs cause it, and most people affected had also had a procedure. If a toe turns purple and painful while you take a blood thinner, call your prescriber right away and get seen the same day, and do not stop the drug yourself.
Where to go next
Sources
- Hirschmann JV, Raugi GJ. Blue (or purple) toe syndrome. Journal of the American Academy of Dermatology 2009;60:1–20.
- Karmody AM, Powers SR, Monaco VJ, Leather RP. ‘Blue toe’ syndrome: an indication for limb salvage surgery. Archives of Surgery 1976;111:1263–1268.
- DermNet. Blue toe syndrome; Cholesterol emboli; Acrocyanosis; Livedo reticularis; Antiphospholipid syndrome; Calciphylaxis.
- Kronzon I, Saric M. Cholesterol embolization syndrome. Circulation 2010;122:631–641.
- Ozkok A. Cholesterol-embolization syndrome: current perspectives. Vascular Health and Risk Management 2019;15:209–220.
- Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Archives of Dermatology 1986;122:1194–1198.
- Merck Manual Professional Version. Renal atheroembolism; Acute limb ischemia; Peripheral artery disease.
- Pawlaczyk K, Gabriel M, Strzelecka-Węklar DA, et al. The usefulness of duplex Doppler ultrasound in the angiological and dermatological diagnosis of patients with blue toe syndrome. Postępy Dermatologii i Alergologii 2017;34:478–484.
- Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. Journal of the American College of Cardiology 2003;42:211–216.
- Scolari F, Ravani P, Gaggi R, et al. The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors. Circulation 2007;116:298–304.
- Baumann DS, McGraw D, Rubin BG, et al. An institutional experience with arterial atheroembolism. Annals of Vascular Surgery 1994;8:258–265.
- DailyMed, US National Library of Medicine. Jantoven (warfarin sodium) tablets: label and medication guide; Activase (alteplase) label.
- MedlinePlus, US National Library of Medicine. Arterial embolism; Thromboangiitis obliterans.
- NHS. Gangrene; Sepsis; Acute kidney injury (AKI); Raynaud’s; Chilblains; Frostbite; Peripheral arterial disease (PAD).
- Centers for Disease Control and Prevention. Your feet and diabetes; National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes and foot problems.
- Ibrahim B, Kattimani R. Phlegmasia cerulea dolens, a deadly complication of deep vein thrombosis: case report and review of literature. Cureus 2021;13:e19927.
- Akella A, Daniel AR, Gould MB, Mangal R, Ganti L. Subungual hematoma. Cureus 2023;15:e48952.
- Scolari F, Ravani P. Atheroembolic renal disease. Lancet 2010;375:1650–1660.
- Wingo JP, Nix ML, Greenfield LJ, Barnes RW. The blue toe syndrome: hemodynamics and therapeutic correlates of outcome. Journal of Vascular Surgery 1986;3:475–480.
- Kvilekval KH, Yunis JP, Mason RA, Giron F. After the blue toe: prognosis of noncardiac arterial embolization in the lower extremities. Journal of Vascular Surgery 1993;17:328–335.
- Tunick PA, Nayar AC, Goodkin GM, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. American Journal of Cardiology 2002;90:1320–1325.
- Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. American Journal of Kidney Diseases 1999;33:840–850.
- Denis Le Seve J, Gourraud Vercel C, Connault J, Artifoni M. Update on cholesterol crystal embolism (in French). La Revue de Médecine Interne 2020;41:250–257.
- Pacchiarini MC, Di Mario F, Greco P, Fiaccadori E, Rossi GM. The controversial role of glucocorticoids in atheroembolic renal disease: a narrative review. Journal of Clinical Medicine 2024;13:6441.
- Hata Y, Iida O, Okamoto S, et al. Clinical outcomes of patients with cholesterol crystal embolism accompanied by lower extremity wound. Angiology 2025;76:32–39.
Written by Tom Biernacki, DPM, FACFAS. Published 12 November 2026. General education, not medical advice.